RP
Rocket Pharmaceuticals Inc
🇺🇸XNAS.RCKTUnited StatesHealthcare
$3.48USDup +0.06 (+1.75%)OpenDelayed6:56 PM
Price$3.48+0.06 (+1.75%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US77313F1066
- CUSIP
- 77313F106
Company
- Employees
- 202
- Headquarters
- Cranbury, United States
- Website
- https://www.rocketpharma.com
- CEO
- Dr. Gaurav D. Shah M.D.
Market
- Shares outstanding
- 109.8M
- Market cap
- $382.02M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $369.94M
- EPS LTM
- -$0.16calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -22.15calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$17.25M+93.3%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$170.4M+17.34%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.